Physician profile
Edward Sun
NPI 1205096567
$1,697.23
in general payments reported to CMS, 2019-2025
11 companies · $19.33 in 2025
The $19.33 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $335 · 2021: $264 · 2022: $75.62 · 2023: $23.47 · 2024: $119 · 2025: $19.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $683.28 | 2019-2025 | Dalvance |
| Ferring Pharmaceuticals INC. | $353.75 | 2019-2020 | |
| Janssen Biotech, INC. | $199.53 | 2020-2022 | |
| Janssen Scientific Affairs, LLC | $119.27 | 2020 | |
| Boston Scientific Corporation | $106.56 | 2019-2024 | Apollo Esg Nxt System |
| Takeda Pharmaceuticals U.S.A., INC. | $98.45 | 2019-2021 | |
| Dova Pharmaceuticals | $35.27 | 2019 | |
| Steris Corporation | $31.00 | 2019 | |
| Pfizer INC. | $29.39 | 2019 | |
| Shire North American Group INC | $24.58 | 2019 | |
| Merck Sharp & Dohme LLC | $16.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.